Home / Health / COVID-19: A new vaccine for UK patients for the first time today | UK News

COVID-19: A new vaccine for UK patients for the first time today | UK News

The Moderna vaccine is going to be given to patients in the UK for the first time today.

The first injections are administered at West Wales General Hospital in Carmarthen, and a total of 5,000 doses are distributed to the vaccination center.

Moderna’s vaccine is the third vaccine approved for use in the UK and will be launched alongside jabs from Pfizer-BioNTech and Oxford University-AstraZeneca.

The UK has purchased 17 million doses of Moderna jab, enough for 8.5 million people, and Phase 3 trials suggest that the vaccine is 100% effective in severe cases. Coronavirus.

Health Minister Matt Hancock said: “I am delighted that we can begin the UK launch of the Moderna vaccine in Western Wales.

“The UK government has endorsed vaccines on behalf of the entire country and the vaccination program has shown that our country is working best together.

“Three out of five people across the UK have received at least one dose and today we start with a third approved vaccine wherever you are. When you get the call, jab.”


Wales Health Minister Vaughan Gething added that the launch of the third vaccine. “It significantly improves our defense when faced with the coronavirus and will help protect our most vulnerable.”

Scotland received the first Moderna vaccine on Monday and a spokesman for the Department of Health said the jab would be launched in England “as soon as this month”.

The UK currently has three approved vaccines - from Pfizer, AstraZeneca, and Modena Fig: AP.
The UK currently has three approved vaccines – from Pfizer, AstraZeneca, and Modena Fig: AP.

Vaccine Minister Nadhim Zahawi said yesterday that the jab was set to be used in “About the third week of April”

It is not yet confirmed when the Moderna launch will begin in Northern Ireland.

According to Moderna, no serious safety concerns have been identified in people receiving the vaccine. Severe events following the first dose included pain around the injection site, while some people report weakness, muscle pain, joint pain, and headache after the second dose.

Please use Chrome browser for a more accessible video player.

Growing concerns about the Oxford vaccine

Occurred after the trial Oxford-AstraZeneca COVID-19 Vaccines for children in the UK Was paused While regular drugs investigate a possible link between prodts and rare blood clots in adults.

A spokesman for the University of Oxford said: “There were no safety concerns” with the study. But more information awaits from the Medicines and Healthcare Products Regulatory Agency (MHRA).

A spokesman for the Department of Health and Social Care said: “No decision has yet been made on whether children should be vaccinated.

“We will receive advice from our experts on these issues, including the independent MHRA and the Joint Committee on Vaccines and Immunization.”

Over the past weekend, it was reported that Coagulation 30 cases Recorded by the MHRA from more than 18 million doses of AstraZeneca injections.

The MHRA confirmed that of the 30, seven died on March 24.

The World Health Organization maintains that the benefits of this vaccine outweigh any risks.

Adam Finn, professor of pediatrics at the University of Bristol, said: “Something is very clear, the first is that these cases are very rare, the second is a vaccine available and in use in the UK. Effectively prevent COVID “

He added: “In the short term, if you are being offered a drug Oxford-AstraZeneca vaccineYour chances of staying alive and being better if you get the vaccine, and going down if you don’t. “

Source link